Taking Mounjaro every 10 days: what the dosing schedule actually allows

The myth worth correcting first: flexibility in the gap is not the same as flexibility in the medicine

A common assumption runs like this: tirzepatide has a long half-life, so spreading injections out a little more should be fine. There is a grain of truth buried in the reasoning (tirzepatide does stay active in the body for several days) but that is exactly why the weekly schedule works as designed, not a reason to extend it.

The half-life of tirzepatide is approximately five days. At a seven-day interval, trough levels (the lowest blood concentration before the next dose) sit within the range that clinical trials showed to be both safe and effective. Extend the gap to ten days and you are operating for three extra days in territory below that tested range. The medicine has not been evaluated at those lower trough levels in the same systematic way. The NHS tirzepatide medicines page is explicit: once weekly, same day each week where possible.

The licensed schedule is not bureaucracy for its own sake. The titration steps (from 2.5 mg upward, typically in four-week increments) were designed around a consistent seven-day rhythm. Disrupting that rhythm, even with good intentions, makes it harder for your prescriber to interpret how you are tolerating a dose and whether a step-up is appropriate.

What the evidence says about the weekly dose, and what it doesn't say about anything else

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled over 2,500 adults with obesity and studied them for 72 weeks on a strict once-weekly schedule. At the 15 mg maintenance dose, average body weight fell by around 20 to 21 percent. That result (often the headline figure you see cited) belongs entirely to a seven-day regimen.

There is no published trial comparing weekly versus every-ten-days tirzepatide in humans. Asking whether 10 days works as well, worse, or differently is a genuinely unanswered question, and unanswered questions are a reason for caution rather than experimentation. The NICE appraisal of tirzepatide (TA1026) bases its recommendation on the same weekly evidence base.

If you are finding weekly injections difficult for practical reasons (travel, supply gaps, anxiety about injection frequency) those are worth raising directly with your prescriber. There may be solutions that keep you within the licensed framework rather than outside it.

If you've already missed a dose or your schedule has slipped

Life does not always cooperate with a weekly reminder. If a dose is late, the practical guidance in the Patient Information Leaflet covers the most common scenario: it can generally be taken within four days of the missed day, and then you return to your regular day going forward. Beyond four days, most guidance suggests skipping that dose and waiting for the next scheduled one. Always check the leaflet and, if in doubt, contact your prescriber or pharmacist the same day, not the following week.

A ten-day gap might happen once by accident. The concern is when someone decides to regularise it, to consciously reframe their schedule as every 10 days rather than every seven. That is when you have left the licensed indication behind entirely. It is also worth being aware that some people searching for extended intervals are doing so because supply has been difficult. If that is the situation you are in, our FAQs page covers what to do when a pen is delayed or unavailable. Speak to your prescriber before making any unilateral change to your schedule.

What a prescriber-led review actually looks like

A question our prescribers hear fairly regularly is some version of: "Can I make it stretch a bit?" The honest answer is always the same, the medicine works on a weekly schedule, and the right conversation is about what is making that schedule difficult, not about whether the medicine will tolerate a longer gap.

At nume, sorry, at a regulated service like ours, every repeat prescription involves a clinical re-review before dispensing. That review exists partly so questions like this get answered properly, not Googled at midnight. If your circumstances have changed, your dose feels wrong, or you are struggling with side effects like nausea that are tempting you to delay injections, that is exactly what the review is for. You can read more about how tirzepatide treatment is structured on our Mounjaro overview page.

For context on eligibility and what a BMI assessment involves before starting treatment, the BMI thresholds for Mounjaro page covers the licensed criteria in full. And if you have ever wondered whether shorter intervals are safer than longer ones, the situation is different but similarly clear, the page on taking Mounjaro every 5 days explains why shortening the gap carries its own set of concerns. If you are curious about injecting slightly ahead of your usual day, our page on taking Mounjaro every 6 days sets out why even a modest shortening of the interval is not straightforward, and if you have considered stretching to just over a week, the page on taking Mounjaro every 8 days explains the concerns around that approach too. If managing nausea is part of why you are considering spacing doses out, our page on taking Imodium alongside Mounjaro may be a more useful starting point than adjusting your schedule.

Ready to talk through your treatment with a prescriber? Check your eligibility and start a free consultation with our clinical team.